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Abstract
Background Elevated lactate and interleukin-6 (IL-6)
levels were shown to correlate with mortality and multiple
organ dysfunction in severely traumatized patients. The
purpose of this study was to test whether an association
exists between 24-hour lactate clearance, IL-6 and pro-
calcitonin (PCT) levels, and the development of infectious
complications in trauma patients.
Methods A total of 1757 consecutive trauma patients
with an Injury Severity Score (ISS) [ 16 admitted over a
10-year period were retrospectively analyzed over a 21-day
period. Exclusion criteria included death within 72 h of
admission (24.5%), late admission [ 12 h after injury
(16%), and age \ 16 years (0.5%). Data are stated as the
median (range).
Results Altogether, 1032 trauma patients (76.2% male)
with an average age of 38 years, a median ISS of 29 (16–
75), and an Acute Physiology, Age, and Chronic Health
Evaluation (APACHE) II score of 14 (0–40) were evalu-
ated. The in-hospital mortality ([3 days) was 10%.
Patients with insufficient 24-hour lactate clearance had a
high rate of overall mortality and infections. Elevated early
serum procalcitonin on days 1 to 5 after trauma was
strongly associated with the subsequent development of
sepsis (p \ 0.01) but not with nonseptic infections. The
kinetics of IL-6 were similar to those of PCT but did dif-
ferentiate between infected and noninfected patients after
day 5.
Conclusions This study demonstrates that elevated early
procalcitonin and IL-6 levels and inadequate 24-hour lac-
tate clearance help identify trauma patients who develop
septic and nonseptic infectious complications. Definition of
specific cutoff values and early monitoring of these
parameters may help direct early surgical and antibiotic
therapy and reduce infectious mortality.
Introduction
Early recognition of trauma patients at risk for the devel-
opment of infectious complications remains a difficult task.
Diagnosis of infection and sepsis can be troublesome in
severely traumatized patients: Positive bacteriologic spec-
imens may be late or absent, the clinical interpretation of
local colonization may be ambiguous, and traditional
infection markers such as core body temperature and white
blood cell (WBC) counts may show nonspecific alterations.
Classic laboratory parameters, such as admission lactate
level, base deficit, and pH, have been extensively investi-
gated with respect to their prognostic significance for
various endpoints, such as sepsis, organ dysfunction, or
death [1–5]. In severely injured patients with an Injury
Severity Score (ISS)[16, serial measurements of one or a
combination of such parameters are helpful for identifying
patients at risk of occult hypoperfusion, subsequent organ
dysfunction, and death. Early on, a correlation was reported
between serum lactic acidosis, the development of septic
shock, and subsequent death in trauma patients [6–8].
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Persistent occult hypoperfusion (POH) in trauma
patients has been proposed to induce a state of relative
immunosuppression, leading to subsequent infection. POH
has been associated with an increase in infections in trauma
patients in a study by Claridge et al. [9], and the authors
demonstrated a good correlation between the time neces-
sary for correction of lactic acidosis and the appearance of
subsequent infection.
With respect to the differentiation between systemic
inflammatory response syndrome (SIRS) and sepsis, pro-
calcitonin (PCT) has been a focus of interest in recent
years. PCT is a precursor of calcitonin, a hormone pro-
duced by the C-cells of the thyroid gland that is essential
for calcium metabolism [10]. The secretion of PCT is not
limited to the thyroid gland and does not occur in healthy
individuals without significant bacteremia [11]. The blood
concentrations of PCT were also reported to show a good
relation with the degree of sepsis [12]. In the acutely
injured patient, PCT was shown to be helpful for differ-
entiating between SIRS and sepsis, and it has outperformed
parameters such as interleukin-6 (IL-6), C-reactive protein
(CRP), and tumor necrosis factor-a (TNFa) in terms of
sensitivity (85%) and specificity (91%), as reported by
Balci et al. [13].
Interleukin-6, our second parameter of interest, is a
proinflammatory cytokine produced by T cells and mac-
rophages to stimulate immune responses to tissue damage
[14]. Certain microbial molecules, termed pathogen-asso-
ciated molecular patterns (PAMPs), bind to Toll-like
receptors on various immune cells, thereby inducing
intracellular signaling cascades, which trigger the produc-
tion of inflammatory cytokines. IL-6 then exerts its various
proinflammatory effects as part of the acute-phase response
through binding to its membrane-bound or soluble IL-6
receptor. Among the best studied effects of IL-6 is the
mobilization of energy precursors from muscle and fat
tissues, leading to increased core body temperature [15].
Both SIRS and sepsis can lead to elevated serum IL-6
levels, with peak values recorded in patients with septic
shock [16]. IL-6 has further been shown to be an inde-
pendent predictor of outcome in unselected critically ill
patients [17]; but despite its obvious diagnostic advantages
in the intensive care unit (ICU) setting, it has yet to become
a parameter of everyday use in clinical practice.
The aim of this study was to assess whether PCT and IL-
6 have a relation with infectious and/or septic complica-
tions in our trauma patient collective. Furthermore, we
hypothesized that impaired 24-hour lactate clearance may
be associated with an increased rate of infectious compli-
cations in trauma patients. Elevated admission lactate level
measurements have been shown to correlate with fatal
outcome and organ failure in trauma patients [4]. In addi-
tion, serial measurements of lactate or lactate clearance
over time may provide a better indicator of organ failure
and mortality in critically ill patients [18–21]. The ideal
threshold by which to define adequate lactate clearance in
critically injured patients, however, remains unresolved.
Patients and methods
We retrospectively analyzed the charts and serum speci-
mens of 1757 severe trauma patients admitted to the
University of Zu¨rich Hospital trauma service between
January 1, 1996 and December 31, 2005. All trauma
patients aged 16 years and older with an ISS [ 16, a
threshold commonly used to define severely injured
patients, were routinely entered into the University of
Zu¨rich Hospital trauma database. Prior to data acquisition,
the study was approved by the ethics committee of the
University of Zu¨rich.
Exclusion criteria included burn injuries, death within
72 h of admission (24.5%), admission after more than 12 h
following trauma (16% of the initial patient collective), and
age \ 16 years. Finally, 1032 patients were included. We
registered and analyzed vital parameters, daily routine, and
laboratory parameters as well as trauma and organ dys-
function scores and indices as outlined in Table 1.
Outcome parameters included length of hospital stay,
length of ICU stay and duration of mechanical ventilation,
overall mortality rates, cause of death, and morbidity
grouped into specific infectious and/or organ dysfunction-
related complications.
Initial stabilization and treatment was performed
according to Advanced Trauma Life Support (ATLS)
guidelines. Basic radiography studies, as well as abdominal
ultrasonography were performed; computed tomography
(CT) scans were obtained for complex injuries in hemo-
dynamically stable patients. If hemodynamic stabilization
of the patient failed, immediate surgical therapy according
to damage control principles followed under supervision of
the attending trauma surgeon. Following initial surgical
therapy, patients were transferred to a specialized trauma
ICU for further stabilization and monitoring.
Definition of infectious complications
Criteria for infection varied depending on the site of
infection. Pneumonia was diagnosed when a predominant
organism was isolated from appropriately obtained sputum
cultures in the setting of purulent sputum production and/or
a new or changing pulmonary infiltrate on chest radiogra-
phy. Bloodstream infections were diagnosed when the
predominant organism was identified in blood cultures
obtained under sterile conditions. Criteria for urinary tract
infections (UTIs) included isolation of [105 organisms/ml
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urine or[104 organisms in patients with symptoms typical
for UTIs. Criteria for catheter-related infection included
isolation of [5 colony forming units (CFU) from catheter
tips cultured only in the setting of suspected infection.
SIRS and sepsis were diagnosed as previously defined in
the literature [22]. Sepsis was diagnosed in patients with an
established (culture-positive) localized or systemic infec-
tion together with four positive SIRS criteria during three
consecutive days. This strict definition of SIRS was chosen
to exclude patients exhibiting a short state of systemic
inflammation as commonly observed following severe
trauma or major surgery [23].
Laboratory measurements
Blood gas analysis and lactate measurements were
obtained using standard radiometers (ABL 800 Flex; Drott
Medizintechnik, Wien Neudorf, Austria). PCT, IL-6, and
CRP were measured using commercially available kits
according to the manufacturer’s instructions: PCT: LU-
MItest PCT, Brahms Diagnostica, Berlin Germany; IL-6:
IL-6 DuoSet ELISA, R ? D Systems, Minneapolis, MN,
USA). Routine hematologic and blood chemistry analyses
(differential WBC count, CRP) were performed by the
clinical hematology and chemistry laboratories at the
University Hospital of Zu¨rich.
24-Hour lactate clearance
Arterial lactate levels were measured consecutively from
day 0 to day 21. A threshold of 2.5 mmol/l was used as a
cutoff value by which to define lactate clearance within
24 h following admission, as previously suggested by
others [24, 25]. According to the individual admission and
24-hour lactate values, patients were divided into four
groups as shown in Fig. 2b: (1) always below 2.5 mmol/l;
(2) decreasing to below 2.5 mmol/l (starting above
2.5 mmol/l but decreasing to below 2.5 mmol/l within
24 h); (3) increasing to above 2.5 mmol/l (starting below
2.5 mmol/l but increasing to above 2.5 mmol/l within
24 h), and (4) always above 2.5 mmol/l. Outcome param-
eters in this analysis were infection or sepsis as defined
above, and death. A second analysis of our lactate clear-
ance data focused on its potential association with the
length of hospital and ICU stays and the length of
mechanical ventilation. Again, a threshold of 2.5 mmol/l
within 24 h was used as a cutoff value by which to define
lactate clearance.
Statistical analysis
Serum parameters were logarithmically transformed before
analysis. One-way analysis of variance (ANOVA) then was
used to detect differences at various time points, followed
by the Holm-Sidak test to isolate the group or groups that
differ from the others. A value of p \ 0.05 was regarded as
statistically significant. To address the problem of multiple
comparisons at different days, p \ 0.01 was considered
statistically significant.
Pearson’s chi-squared test followed by Fisher’s exact
test with Bonferroni correction was used to identify sig-
nificant changes between two corresponding groups. For
data that were not normally distributed, the Kruskal-Wallis
test or the Mann-Whitney rank-sum test (according to the
Table 1 Overview of the patients enrolled
General information
No. of patients 1032
Age (years) 38 (16–88)
Sex: male (%) 76.2
Mechanism of injury: blunt (%) 90.4
Type of injury (%)
Traffic 53
Work 12.2
Suicide 7.75
Other 7.1
ISS 29 (16–75)
NISS 41 (16–75)
Admission parameters
MAP (mmHg) 92 (0–175)
Shock class (ATLS) 1 (0–4)
Glasgow Coma Scale 8 (3–15)
Lactate (mmol/l) 2.4 (0.4–20.1)
Base excess (mmol/l) -3.0 (-34.9 to 7.5)
pH 7.33 (6.0–8.94)
Temperature (C) 35.7 (24.5–39.2)
APACHE II score 14 (0–40)
Course of hospital stay
Length of hospital stay (days) 20 (1–167)
Length of ICU stay (days) 9 (0–101)
Length of mech. Ventilation (days) 5 (0–101)
Cause of death (%) 10.3
Head injuries 5.6
Sepsis 2.3
MOF 1.6
Other 0.8
Day of death 10 (4–101)
Data are listed as median (range) or as stated in the table. Admission
lactate refers to the first arterial lactate value obtained in the trauma
room, usually during the initial phase of resuscitation
ISS Injury Severity Score; NISS New Injury Severity Score; MAP
mean arterial pressure; GCS Glasgow Coma Scale; APACHE II Acute
Physiology, Age, and Chronic Health Evaluation II score; ICU
intensive care unit; MOF multiple organ failure
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number of groups) was applied. Stepwise logistic regres-
sion was then performed using the following parameters:
age, sex, ISS, mean arterial pressure (MAP), systolic blood
pressure, Glasgow Coma Scale (GCS), PCT, IL-6, and
lactate clearance group always [2.5 mmol/l. For the step-
wise logistic regression, IL-6 and PCT values from days 1
and 2 as well as values from days 2 and 3 were combined.
Receiver operating characteristic (ROC) curves were gen-
erated for the parameters listed above for days 1 and 2.
Data are presented as the median (range) or
mean ± standard error of the mean (SEM), as appropriate.
Statistical analysis was performed using both SigmaStat
3.01.0 (Systat Software, Richmond, CA, USA) and SPSS
15.0 software (SPSS, Chicago, IL, USA).
Results
An overview of the patient collective enrolled into this
study is provided in Table 1. Most of the patients were
male (76.2%) and suffered from blunt trauma (90.4%);
10.2% died from their injuries. Head and neck trauma
accounted for most of the fatal injuries.
Comparison of IL-6 and PCT with common clinical
immunologic parameters
Procalcitonin levels are depicted in Fig. 1a. The highest
PCT values were observed on day 1 in patients who later
developed septic infections (i.e., 3.82 ± 0.99 ng/ml in the
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Fig. 1 Comparison of commonly used laboratory markers of inflam-
mation and infection in trauma patients. *Significant difference
(p \ 0.01), no-infection group vs. sepsis group. p \ 0.01, infection
group vs. sepsis group; p \ 0.05, no-infection group vs. sepsis
group. §p \ 0.05, infection group vs. sepsis group. IIp \ 0.05, no-
infection group vs. infection group. a Serum procalcitonin levels. b
Serum interleukin-6 levels. c Leukocyte count. d Serum C-reactive
protein values
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sepsis group versus 0.81 ± 0.1 ng/ml in controls without
infection on day 1, p \ 0.0001). PCT values in subse-
quently septic patients were also higher than PCT levels
recorded in patients with isolated infections up until day 5
after trauma. There is no significant difference between
PCT values in patients with nonseptic infections
(1.54 ± 0.55 ng/ml) and in patients without infection
(p = 0.97) on day 1 or on any following day. PCT values
decreased in all groups after day 1 but were still signifi-
cantly different between the sepsis group and the two other
groups until day 5 after trauma (p \ 0.01 for every day).
With respect to IL-6 (Fig. 1b), patients with a septic
course showed highest levels on day 1 after trauma
(551.6 ± 124.1 ng/l compared to 282.1 ± 39.8 ng/l in
patients without infections, p = 0.28). However, the dif-
ference between subsequently septic patients and
noninfected patients reached statistical significance only
between days 3 and 7, after which all three groups slowly
returned to baseline values.
Figure 1c illustrates WBC counts. During the initial
5 days, a significant decrease in the WBC count was
observed in all three groups compared to admission (day 0)
values. The lowest values were reached on day 1 in the sepsis
group (8.01 ± 0.28 9 103 cells/ll) compared to the no-
infection group (9.75 ± 0.17 9 103 cells/ll; p \ 0.0001)
and the nonseptic infection group (8.63 ± 0.26 9 103 cells/
ll; p = 0.008). From day 7 onward, patients in the sepsis
group displayed higher WBC counts than the other two
patient groups, although these differences approached sta-
tistical significance only on days 7 and 14 (both p \ 0.05).
C-reactive protein levels (Fig. 1d) showed a steady
increase in all three groups following trauma, reaching peak
levels around 150 mg/dl between days 3 and 7. On day 0, we
found slightly (but approaching significantly) lower CRP
levels in the sepsis group (7.3 ± 2.52 mg/dl) compared to
the no-infection group (9.58 ± 1.25 mg/dl; p = 0.022).
After day 7, CRP levels returned to baseline levels earlier in
noninfected patients than in those with localized infections
or sepsis, whose levels were significantly higher on days 5,
7, and 14 (all p \ 0.01). Even on day 21, CRP levels aver-
aged 90 mg/dl in the sepsis group versus 62 mg/dl in the no-
infection group, indicating the long period of recovery from
both sepsis and major trauma in general.
Blood lactate and 24-hour lactate clearance
Figure 2a shows the course of lactate concentrations over
14 days following major trauma, with the highest levels
upon admission in all groups. Admission lactate levels in
subsequently septic patients (2.27 ± 0.12 mmol/l) were
significantly higher than those observed in patients without
infections (1.89 ± 0.07 mmol/l; p = 0.006) and remained
highest in this group until day 5 after trauma (all p \ 0.01).
Patients who developed localized infections trended to
higher lactate levels on days 1 and 3 after trauma when
compared to patients who did not develop any infections
(p = 0.011 and 0.022, respectively, for days 1 and 3).
However, all groups displayed ‘‘physiologic’’ lactate val-
ues (\1.2 mmol/l) after day 3, and any observed
differences from this day onward were minor in magnitude
and potentially without clinical significance.
Figure 2b illustrates 24-hour lactate clearance using a
cutoff value of 2.5 mmol/l. The rate of infectious compli-
cations in all groups was at least at 39%, reaching its
highest value in the ‘‘always above 2.5 mmol/l’’ group with
an infection rate of 70% (p \ 0.0001). The mortality rate in
the ‘‘increasing above 2.5 mmol/l’’ group was twice as
high (21%) as the mortality rate in the other three groups
(around 10%), but this difference did not reach statistical
significance. The rate of septic infections, on the other side,
was markedly lower in the ‘‘always below 2.5 mmol/l
group’’ (19.3%) than in the ‘‘always above 2.5 mmol/l
group (53.7%, p \ 0.0001).
Figure 2c shows the relation between 24-hour lactate
clearance and the length of hospital and ICU stays and the
length of mechanical ventilation. We found that patients with
continuously high (always above 2.5 mmol/l) lactate levels
stayed in the hospital the longest (38.4 ± 3.2 days), which
was significant especially when compared to patients with
always low lactate levels (24.1 ± 0.8 days, p \ 0.0001). The
longest ICU stay and longest need for mechanical ventilation
were seen in the group of patients with lactate levels always
above 2.5 mmol/l (27.8 ± 6 and 23.0 ± 5 days, respec-
tively; p \ 0.0001 for both parameters compared to the group
of patients with lactate levels always below 2.5 mmol/l).
Logistic regression and ROC curve
Stepwise logistic regression from days 1 ? 2 support the
results from the initial univariate analysis; ISS (p = 0.013),
IL-6 (p = 0.008), and PCT (p = 0.032) remained inde-
pendent predictors of septic infections in our patient
population. On days 2 ? 3, both IL-6 (p \ 0.001) and
lactate clearance ‘‘always above 2.5 mmol/l’’ (p = 0.013)
were independent predictors of sepsis. The ROC curve is
shown in Fig. 3, with the bold line marking the prognostic
index of the assessed parameters. The comparably low
sensitivity of lactate clearance ‘‘always above 2.5 mmol/l’’
reflects the low patient numbers in this subgroup (n = 13).
Discussion
The definition of specific parameters by which to identify
trauma patients at risk of developing infectious complica-
tions and sepsis at an early stage remains a crucial goal of
562 World J Surg (2009) 33:558–566
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laboratory research in trauma surgery. We have previously
shown that PCT is a sensitive and predictive indicator of
sepsis and severe MODS in trauma patients [26]. Its use in
the early distinction between SIRS and sepsis has further
facilitated the identification of patients requiring antibiotic
therapy or surgical intervention to control infectious foci
[13]. The data from our present study show that trauma
patients who later develop septic complications have ini-
tially high PCT levels and fail to clear initially elevated
blood lactate levels within 24 h. PCT shows peak levels
within the first 48 h following trauma, whereas WBC
counts and CRP levels increase later and fail to distinguish
between septic and nonseptic patients during the first days.
Interleukin-6 may help identify patients at risk for septic
complications after at least 3 days following trauma, but its
association was, in our series of patients, less stringent when
compared to PCT as an isolated parameter. Logistic step-
wise regression confirmed this association; PCT in the early
days after severe trauma is an independent predictor of
septic infections, making it a useful prognostic parameter
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Fig. 2 a Arterial lactate measurements as a function of the time
following trauma. Day 0 lactate is defined as the first measured lactate
upon arrival in the intensive care unit (ICU), which is usually lower
than the initial value measured in the trauma room (see Table 1,
admission value). *p \ 0.01, no-infection group vs. sepsis group. 
p \ 0.01, infection group vs, sepsis group. p \ 0.05, no-infection
group vs. sepsis group. §p \ 0.05, infection group vs. sepsis group.
IIp \ 0.05 no-infection group vs. infection group. b Development of
lactate levels within the first 24 h following admission. Grouping was
performed according to the development of arterial lactate levels
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l’’ = initial lactate \ 2.5 mmol/l, 24-hour lactate [ 2.5 mmol/l).
*p \ 0.013, ‘‘always below’’ group vs. ‘‘always above’’ group. c
Association between 24-hour lactate clearance and length of hospital
stay, ICU stay, and length of mechanical ventilation. *p \ 0.05,
‘‘always below 2.5 mmol/l’’ group vs. ‘‘decreasing below 2.5 mmol/
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during the early treatment of such patients. IL-6 as another
independent predictor of sepsis during the first 3 days after
major trauma deserves similar attention despite its so far
uncommon use in everyday clinical practice.
The ISS is another predictor of sepsis in our patient
cohort, as had been shown previously [27].
Herein may lie the advantage of the combined use of
PCT and IL-6; together, these parameters help differentiate
patients with a subsequently septic course from patients
who develop localized, nonseptic infections. These findings
are strikingly similar to a series of 90 trauma patients
reported by Meisner et al. [28], who found characteristics
of PCT and CRP levels comparable to those recorded in
our patients. Those authors showed a significant associa-
tion between early increases in PCT and sepsis, especially
septic shock. CRP levels failed to indicate specific infec-
tious complications in their trial, although overall both
PCT and CRP levels tended to be higher in nonsurvivors
than survivors [28]. Castelli et al., in their comparison of
the diagnostic value of PCT and CRP in 150 ICU patients,
came to similar conclusions but found that CRP concen-
trations were induced nearly to their maximum during less
severe symptoms of systemic inflammation and organ
dysfunction and did not further increase during more
severe stages of the disease [29].
The use of PCT as a diagnostic tool to differentiate
between SIRS and sepsis has been questioned by several
authors [30, 31]. Suprin et al. found sensitivity and speci-
ficity values as low as 65% and 70% for PCT using 2.0 ng/
ml as a cutoff value, with similar results for the use of CRP
[30]. Tang et al. reported 71% sensitivity and specificity for
PCT in their meta-analysis of 18 clinical trials [31]. The
authors found an ‘‘upwardly biased’’ performance of PCT in
smaller studies, which moved toward a null effect in larger
trials; the authors concluded that the present data may not
support the current widespread use of PCT in ICU practice.
Other authors came to more favorable conclusions
regarding the specific use of PCT in selected patient pop-
ulations [32, 33]. Svoboda et al. showed a significant
decrease in ICU mortality in 72 patients with a suspected
septic focus following major injury or multiple surgery by
using PCT as an aid to deciding on early reintervention
[32]. The control group in this trial underwent the same
clinical and laboratory reevaluation but without PCT
measurement. The group receiving PCT-guided treatment
further benefited from a shorter ICU stay and fewer days on
the ventilator, although these differences were not signifi-
cant. A recent meta-analysis by Uzzan et al., however,
concluded from 49 clinical trials that PCT indeed aids the
clinical diagnosis of sepsis and septic shock in postopera-
tive and trauma patients [33]. The authors underlined the
need to incorporate biomarkers such as PCT into an overall
assessment of critically ill patients rather than in preference
to clinical evaluation. In this study we showed that PCT is
capable of identifying patients at risk of infectious, espe-
cially septic, complications at the beginning of their
recovery period, which may further aid in the identification
of patients at risk of such complications.
Interleukin-6 has been extensively investigated as a
marker of systemic inflammation following trauma and
surgery. Its kinetics during the early days following major
trauma are well documented [14, 34–36], and several
studies have shown a significant correlation between peak
IL-6 levels and the development of SIRS and sepsis in such
patients [16, 36, 37]. Animal studies have shown that
concentrations of IL-6 correlate with the extent of injury
[38], and the authors of a recent study have even proposed
the use of IL-6 as a forensic tool to distinguish between
traumatic and non-trauma-related deaths [39].
In our data collection, we found comparable results with
the highest IL-6 levels on day 1 in patients who later
developed sepsis. From a clinical point of view, however, it
is important to note that, in contrast to PCT, IL-6 does not
indicate the presence of bacterial infection and may not be
(mis-)used in trying to diagnose occult infections [33]. The
value of IL-6 is as an index of systemic inflammation, which
in itself has prognostic significance. A recent comparison of
the prognostic value of IL-6, PCT, and CRP in febrile ICU
patients demonstrated that IL-6 was a better predictor of
mortality in this group of patients, and the authors suggested
its use as a tool to identify patients who could benefit from
intensive monitoring and early specific therapy [40].
Fig. 3 Receiver operating characteristic (ROC) curve of the inde-
pendent predictors on days 1 and 2. ISS Injury Severity Score
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The third focus of our study was on the use of arterial
lactate, its clearance within 24 h, and its association with
infectious complications in our patient collective. We found
that initial lactate levels can differentiate between patients
with an eventually septic course and those without it.
Moreover, its course over the first 24 h provided a tool to
identify patients at risk for the development of infection,
sepsis, and death. Similar to the incidence of specific infec-
tious complications, we found that failed or insufficient
lactate clearance (\2.5 mmol/l) within 24 h is associated
with significantly longer hospital and ICU stays and
increased duration of mechanical ventilation. These findings
are further supported by the fact that failed 24-hour lactate
clearance is another predictor of septic infections in our
patient cohort. The threshold of 2.5 mmol/l at 24 h following
injury was chosen based on a series of preliminary analyses
using different concentrations of lactate at time points
between 6 h and up to 48 h. The most consistent results were
found after 24 h using 2.5 mmol/l, which is consistent with
findings from two other trials, in which this threshold was
used [24, 25]. Kobayashi et al. studied 22 patients with SIRS
and focused on the development of disseminated intravas-
cular coagulation (DIC) and death as a function of serial
lactate measurements [24]. The authors found that a lactate
concentration of 2.5 mmol/l on day 1 provided an optimal
cutoff point, defined as the best prognostic value for pre-
dicting subsequent death in patients with SIRS.
In line with our findings, Durham et al. showed in 2003
that elevated 24-hour lactate levels can predict better the
incidence of both single and multiple organ failure in
trauma patients than admission lactate levels alone in their
study of 869 patients treated at a Level I trauma center [21].
Using multivariate regression analysis, the authors found
that only the Acute Physiology, Age, and Chronic Health
Evaluation (APACHE) III, total blood products transfused
within 24 h, and lactate levels at 24 h were associated with
multiple organ failure. However and unfortunately, a more
in depth analysis of lactate clearance at different thresholds
is missing in their analysis. With respect to the diagnostic
value of admission lactate values, a thorough analysis was
conducted by Pal et al. recently [1]. In their study on 6000
trauma patients, the authors failed to show useful predictive
values for hospital death using admission arterial lactate as
a single parameter after stratification for age, sex, and ISS,
among other parameters [1]. Similar to our results, high
lactate values were also found in patients who died, but
considerable overlap existed, preventing raw lactate values
from accurately discriminating between survivors and
nonsurvivors. A point to mention is that this study included
all trauma admissions regardless of the ISS, thereby com-
prising a large number of minimally injured patients, and
the authors did indeed recommend using lactate levels as a
parameter of occult hypoperfusion in ICU trauma patients.
Finally, Phua et al. have recently demonstrated that a
concurrent increase of both PCT and lactate between days
1 and 2 after trauma had the highest value in predicting 28-
day mortality in patients with septic shock [41]. The
combination of the two parameters superseded all inde-
pendent cytokine measurements or clinical severity scores
in their trial of 72 patients. Similar to our findings, the
authors found only poor prognostic utility of baseline lac-
tate values. Unfortunately, although serial lactate
measurements over the first 72 h were recorded, no specific
analysis of lactate clearance was performed in their trial.
The limitations of our study should be noted. First, patient
data were collected during a 10-year period, during which the
care of trauma patients has continuously evolved. Despite
such changes in the clinical management, overall mortality
in our trauma patient collective has not significantly changed
during this time period. In addition, both the head of our
Division of Trauma Surgery and that of Surgical Intensive
Care did not change during this period, providing consis-
tency with respect to the clinical management of trauma
patients in our institution. Second, patients with severe
trauma comprise a highly heterogeneous group of critically
ill patients who may exhibit different immunologic respon-
ses depending on the injury sustained. We tried to control for
this fact by selecting only adult trauma patients who survived
at least 72 h and not including late referrals from other
hospitals, pediatric patients, or those with burn injuries,
thereby excluding the more obviously differing subgroups.
Conclusions
We found a significant positive association between early
elevations of both PCT and IL-6 and infectious complica-
tions in our collective of 1032 trauma patients. Similarly,
delayed or absent 24-hour lactate clearance helped identify
patients at risk of infectious complications and of subse-
quently prolonged ICU and hospital stays. Despite the
ongoing strong interest for PCT as a reliable early marker
of bacterial infection in critically ill patients, we believe
that a combination of clinical and select laboratory
parameters yields better prognostic value and provides a
tool by which to guide specific therapeutic interventions.
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